Sera Prognostics, Inc.
SERANASDAQHealthcareMedical - Diagnostics & Research
Previous close
$2.14
+$0.04 · +1.90%
Pre-market
$2.07
−$0.07 · -3.27%
Aug 24, 4:19 AM ET
SERA company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
25
Expensive
Momentum
27
Weakening
Sentiment
57
Mixed
Risk resilience
26
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Zhenya Lindgardt
- Listed since
- Jul 15, 2021
- Employees
- 72
Market position
Day range
Current $2.14
52-week range
Current $2.14
- Open
- $2.07
- Previous close
- $2.10
- Volume
- 14.57K
- 0.32× average
- Average volume
- 45.65K
- Average daily volume
- Market cap
- 81.73M USD
- Beta
- 0.98
- Market reference 1
- 50-day average
- $1.9904
- +7.52% above average
- 200-day average
- $2.4168
- -11.45% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 139M USD
- P/E (TTM)
- -3.19×
- P/B (TTM)
- 1.82×
- P/S (TTM)
- 1,167.55×
- EV / EBITDA
- -4.49×
- Earnings yield
- -22.71%
- Free cash flow yield
- -18.74%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- -150.00%
- Operating margin
- -53282.86%
- Net margin
- -47475.71%
- Return on equity
- -42.34%
- Return on assets
- -31.32%
- Return on invested capital
- -46.95%
Financial health
- Debt / equity
- 0.05×
- Current ratio
- 1.69×
Earnings
- EPS beat rate
- 36%
- 4 beats, 6 misses, 1 met estimate
- Average EPS surprise
- +0.36%
- 11 comparable reports
- Latest EPS result
- -0.18
- Estimate -0.15 · Miss by 16.72%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$6.00
180.37% upsidePrice history unavailable
High $6.00Average $6.00Low $6.00Rating distribution
5 ratingsSERA peers
ETFs holding SERA
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.81M0.00%2.3T USD0.03%$378.24+0.44%
Vanguard Extended Market ETFVXF775.63K0.00%93.7B USD0.05%$245.53+0.82%
iShares Micro-Cap ETFIWC217.78K0.01%1.53B USD0.60%$198.39+1.10%
Avantis U.S. Small Cap Equity ETFAVSC11.35K—3.16B USD0.25%$73.84+0.70%
Dimensional - US Core Equity 1 ETFDCOR10.92K0.00%3.51B USD0.14%$84.54+0.42%Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 1.81M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Extended Market ETFVXF- Market value
- 775.63K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Micro-Cap ETFIWC- Market value
- 217.78K
- Weight
- 0.01%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Avantis U.S. Small Cap Equity ETFAVSC- Market value
- 11.35K
- Weight
- —
- AUM
- 3.16B USD
- Expense ratio
- 0.25%
- Price / 1D
- $73.84+0.70%
Dimensional - US Core Equity 1 ETFDCOR- Market value
- 10.92K
- Weight
- 0.00%
- AUM
- 3.51B USD
- Expense ratio
- 0.14%
- Price / 1D
- $84.54+0.42%
Continue in GoAI
Research SERAresearch.disclaimer